U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103148) titled 'A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population' on July 07.
Brief Summary: The purpose of this study is to determine whether vYF (investigational vaccine) is safe and can help the body to develop antibodies (immunogenicity) compared with Stamaril vaccine and YF-VAX vaccine (both licensed vaccines) and when they are co-administered with Measles Mumps Rubella (MMR) vaccines in infants aged 11-15 months.
Number of Participants:
A total of 2440 participants is planned to be enrolled in VYF04 study.
Study Arms and Duration:
Eligible participants will be randomized in 2 independent groups (9-2...